Hagens Berman Securities Lawyers

Sound investment decisions can only be made when you have full disclosure of accurate information. No money manager, retirement fund or individual investor should suffer undue risk and incur losses due to misrepresentations related to the investment at issue.

Our attorneys work for defrauded institutional and individual investors impacted by poor corporate governance, breach of fiduciary duties, or a failure of good faith, fair dealing or loyalty. The firm vigorously pursues fraud recovery litigation, forcing corporate officers, directors and fund managers to answer to their investors.

Below are cases in active investigation or cases with deadlines class members must meet in order to be considered a lead plaintiff. For further information on each, click on the links below and provide the requested information, or contact Reed Kathrein or Peter Borkon at 510-735-3000.

New Actions/
Investigations

Ticker
Lead Plaintiff
Deadline
Intuitive Surgical, Inc. NASDAQ: ISRG June 25, 2013
Magnum Hunter Resources Corp. NYSE: MHR June 24, 2013
Star Scientific, Inc. NASDAQ: STSI May 24, 2013
Tech Data Corporation NASDAQ: TECD  
Spectrum Pharmaceuticals, Inc. NASDAQ: SPPI May 13, 2013
Apollo Group Inc. NASDAQ: APOL  
Mantria Securities   March 1, 2013
Abiomed NASDAQ: ABMD January 15, 2013